EP 1740190 A1 20070110 - USE OF A MIXTURE FOR THE PRODUCTION OF AN AGENT FOR TREATING DEFECTIVE OR DEGENERATED CARTILAGE IN THE PRODUCTION OF NATURAL CARTILAGE REPLACEMENT IN VITRO
Title (en)
USE OF A MIXTURE FOR THE PRODUCTION OF AN AGENT FOR TREATING DEFECTIVE OR DEGENERATED CARTILAGE IN THE PRODUCTION OF NATURAL CARTILAGE REPLACEMENT IN VITRO
Title (de)
VERWENDUNG EINES GEMISCHES FÜR DIE HERSTELLUNG EINES MITTELS ZUR BEHANDLUNG VON DEFEKTEM ODER DEGENERIERTEM KNORPEL IN VIVO UND BEI DER HERSTELLUNG VON NATÜRLICHEM KNORPELERSATZ IN VITRO
Title (fr)
UTILISATION D'UN MELANGE POUR PRODUIRE UN AGENT SERVANT A TRAITER UN CARTILAGE DEFECTUEUX OU DEGENERE IN VIVO ET POUR PRODUIRE UN SUBSTITUT DE CARTILAGE NATUREL IN VITRO
Publication
Application
Priority
CH 2004000131 W 20040305
Abstract (en)
[origin: WO2005084684A1] A mixture of one or several substances from group A) lubricin, proteoglycan 4 (PRG4) and phospholipid (SAPL); with one or several substances from group B) hyaluronic acid, glycosaminoglycan and derivatives of said substances; dissolved in a solvent, used for the production of an agent for treating defective or degenerated cartelage in vivo. Said mixture can also be used to produce natural cartilage replacement in vitro.
IPC 8 full level
A61K 31/661 (2006.01); A61K 31/726 (2006.01); A61K 31/728 (2006.01); A61K 38/17 (2006.01); A61P 19/02 (2006.01)
CPC (source: EP US)
A61K 31/661 (2013.01 - EP US); A61K 31/726 (2013.01 - EP US); A61K 31/728 (2013.01 - EP US); A61K 38/17 (2013.01 - EP US); A61P 19/02 (2017.12 - EP)
Citation (search report)
See references of WO 2005084684A1
Designated contracting state (EPC)
CH DE FR GB LI
DOCDB simple family (publication)
WO 2005084684 A1 20050915; CA 2558497 A1 20050915; EP 1740190 A1 20070110; US 2007275032 A1 20071129
DOCDB simple family (application)
CH 2004000131 W 20040305; CA 2558497 A 20040305; EP 04717539 A 20040305; US 59183304 A 20040305